Topics
Glioblastoma | Treatment | Clinical trials | Abemaciclib
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Abemaciclib
Chen J, Oberheim Bush NA, Grabowsky JA, Kline C, Kroetz DL, Taylor
JW, Villanueva-Meyer J, Molinaro AM, de Groot JF, Butowski NA,
Tedesco M, Rabbitt J, Phillips JJ, Hervey-Jumper S, Aghi MK,
Berger MS, Chang EF, Chang SM, Solomon DA, Clarke JL.
A
genomically-tailored multi-agent precision medicine clinical trial
for adults with recurrent glioblastoma.
Clin
Cancer Res. 2026 Feb 6. doi:
10.1158/1078-0432.CCR-25-4080. PMID:
41649856. Interventional study.
ˍ
Rudra Gupta T, Polley MC, Redd R, Lee EQ, Arrillaga-Romany I,
Gilbert MR, Tan Y, Touat M, Drappatz J, Welch MR, Galanis E,
Ahluwalia MS, Colman H, Nabors LB, Hepel J, Elinzano H, Schiff D,
Chukwueke UN, Beroukhim R, Nayak L, McFaline-Figueroa JR,
Batchelor TT, Kaley TJ, Lu-Emerson C, Mellinghoff IK, Bi WL,
Arnaout O, Peruzzi PP, Haas-Kogan D, Tanguturi S, Aizer A, Doherty
L, Santagata S, Meredith DM, Chiocca EA, Reardon DA, Ligon KL,
Weller M, Mehta MP, Wen PY, Trippa L, Rahman R.
Treatment
Effect Reanalysis of the Randomized Individual Screening Trial of
Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma
With External Control Data.
J
Clin Oncol. 2026 May 22:JCO2501586. doi:
10.1200/JCO-25-01586. PMID:
42172567. Trial
registration ID: NCT02977780˰
ˍ